SA PRO
Free Account
Charles River Laboratories International, Inc.CRLNYSE
LOADING
|||
OverviewNewsChartFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 67% recommend buying.

Consensus Rating
Buy
24 analysts·High coverage
67%
Rating Distribution
Strong Buy
00%
Buy
1667%
Hold
833%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 7% above analyst consensus — modest downside expected.

Bear Case
$185.00
-16%
Base Case
$204.86
-7%
Bull Case
$224.00
+1%
Price Range24 analysts
Low
Consensus
High
$185.00
$224.00
Current Target
Current Price
$220.91
Above Target
$16.05

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 9, 2026Robert W. Baird
Charles River price target raised to $224 from $199 at Baird
Target:$224.00
+2.1%from $219.49
Jan 9, 2026Mizuho Securities
Charles River price target raised to $215 from $200 at Mizuho
Target:$215.00
-0.2%from $215.51
Dec 18, 2025Mizuho Securities
Charles River price target raised to $200 from $174 at Mizuho
Target:$200.00
+2.1%from $195.98
Dec 15, 2025Barclays
Charles River price target raised to $215 from $210 at Barclays
Target:$215.00
+11.4%from $192.97
Dec 1, 2025Morgan Stanley
Morgan Stanley Assumes Charles River Labs (CRL) at Equalweight
Target:$185.00
+5.1%from $176.09
Nov 17, 2025Argus Research
Charles River upgraded to Buy from Hold at Argus
Target:$200.00
+20.0%from $166.73
Oct 17, 2025Mizuho Securities
Charles River price target raised to $174 from $155 at Mizuho
Target:$174.00
-0.5%from $174.95
Oct 3, 2025Evercore ISI
Charles River price target raised to $200 from $190 at Evercore ISI
Target:$200.00
+10.4%from $181.18
Oct 2, 2025Barclays
Charles River upgraded to Overweight from Equal Weight at Barclays
Target:$195.00
+14.4%from $170.48
Sep 9, 2025Jefferies
Charles River upgraded to Buy from Hold at Jefferies
Target:$195.00
+23.9%from $157.38
Oct 15, 2024Barclays
Charles River price target lowered to $205 from $210 at Barclays
Target:$205.00
+6.1%from $193.14
Oct 14, 2024Redburn Partners
Charles River initiated with a Sell at Redburn Atlantic
Target:$151.00
-21.7%from $192.97
Sep 17, 2024Mizuho Securities
Mizuho Reiterates Neutral Rating on Charles River Labs (CRL)
Target:$210.00
+1.7%from $206.44
Aug 8, 2024Deutsche Bank
Charles River price target lowered to $240 from $300 at Deutsche Bank
Target:$240.00
+19.8%from $200.34
Jul 10, 2024Robert W. Baird
Charles River price target lowered to $239 from $271 at Baird
Target:$239.00
+18.4%from $201.85
Jun 28, 2024Barclays
Barclays Starts Charles River Labs (CRL) at Equalweight
Target:$230.00
+10.9%from $207.35
Jun 6, 2024Goldman Sachs
Goldman Sachs Starts Charles River Labs (CRL) at Buy
Target:$290.00
+34.2%from $216.12
May 9, 2024Evercore ISI
Charles River Labs (CRL) PT Lowered to $265 at Evercore ISI
Target:$265.00
+15.2%from $230.09
Apr 1, 2024Evercore ISI
Charles River Labs (CRL) PT Raised to $300 at Evercore ISI
Target:$300.00
+10.7%from $270.95
May 5, 2022KeyBanc
Charles River Laboratories (CRL) Stock: $300 Price Target And Overweight Rating
Target:$300.00
+16.5%from $257.51
Apr 25, 2022Wells Fargo
Wells Fargo Maintains Overweight on Charles River, Lowers Price Target to $325
Target:$325.00
+26.1%from $257.75
Apr 25, 2022Jefferies
Charles River downgraded to Hold from Buy at Jefferies
Target:$280.00
+2.6%from $273.03
Jan 11, 2022Jefferies
Wall Street Analysts Are Bullish on Top Services Picks
Target:$464.00
+29.6%from $357.95
Nov 24, 2021Argus Research
Charles River Labs (CRL) PT Lowered to $440 at Argus
Target:$440.00
+16.6%from $377.51
Aug 17, 2021Cowen & Co.
Charles River price target raised to $465 from $390 at UBS
Target:$465.00
+11.4%from $417.45

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance